Webinário a pedido
Dados clínicos e de investigação mais recentes sobre as LIO trifocais
26 junho 2020
· 42 MIN VISUALIZAÇÃO
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/570-on-demand-webinar-latest-clinical-data-and-research-on-trifocal-iol-technology/lahood.jpg/_jcr_content/renditions/original.image_file.100.100.14,0,329,315.file/lahood.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/570-on-demand-webinar-latest-clinical-data-and-research-on-trifocal-iol-technology/lahood.jpg/_jcr_content/renditions/original.image_file.315.315.14,0,329,315.file/lahood.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/570-on-demand-webinar-latest-clinical-data-and-research-on-trifocal-iol-technology/lahood.jpg/_jcr_content/renditions/original.image_file.315.315.14,0,329,315.file/lahood.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/570-on-demand-webinar-latest-clinical-data-and-research-on-trifocal-iol-technology/lahood.jpg/_jcr_content/renditions/original.image_file.315.315.14,0,329,315.file/lahood.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/570-on-demand-webinar-latest-clinical-data-and-research-on-trifocal-iol-technology/lahood.jpg/_jcr_content/renditions/original.image_file.315.315.14,0,329,315.file/lahood.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/570-on-demand-webinar-latest-clinical-data-and-research-on-trifocal-iol-technology/lahood.jpg/_jcr_content/renditions/original.image_file.315.315.14,0,329,315.file/lahood.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/570-on-demand-webinar-latest-clinical-data-and-research-on-trifocal-iol-technology/lahood.jpg/_jcr_content/renditions/original.image_file.315.315.14,0,329,315.file/lahood.jpg"})
Autor
Dr. Ben LaHood
Eye Institute, Auckland, Nova Zelândia
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/570-on-demand-webinar-latest-clinical-data-and-research-on-trifocal-iol-technology/gupta.jpg/_jcr_content/renditions/original.image_file.100.100.1,0,343,342.file/gupta.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/570-on-demand-webinar-latest-clinical-data-and-research-on-trifocal-iol-technology/gupta.jpg/_jcr_content/renditions/original.image_file.342.342.1,0,343,342.file/gupta.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/570-on-demand-webinar-latest-clinical-data-and-research-on-trifocal-iol-technology/gupta.jpg/_jcr_content/renditions/original.image_file.342.342.1,0,343,342.file/gupta.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/570-on-demand-webinar-latest-clinical-data-and-research-on-trifocal-iol-technology/gupta.jpg/_jcr_content/renditions/original.image_file.342.342.1,0,343,342.file/gupta.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/570-on-demand-webinar-latest-clinical-data-and-research-on-trifocal-iol-technology/gupta.jpg/_jcr_content/renditions/original.image_file.342.342.1,0,343,342.file/gupta.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/570-on-demand-webinar-latest-clinical-data-and-research-on-trifocal-iol-technology/gupta.jpg/_jcr_content/renditions/original.image_file.342.342.1,0,343,342.file/gupta.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/570-on-demand-webinar-latest-clinical-data-and-research-on-trifocal-iol-technology/gupta.jpg/_jcr_content/renditions/original.image_file.342.342.1,0,343,342.file/gupta.jpg"})
Autor
Dra. Aanchal Gupta
Adelaide Eye & Laser Centre, Adelaide, Austrália
RESUMO
Dados clínicos e de investigação mais recentes sobre as LIO trifocais
As LIO multifocais foram especificamente concebidas para permitir uma boa visão sem ajuda numa série de distâncias, que é o resultado final desejado por todos os pacientes. No entanto, com tantas opções disponíveis no mercado, qual delas é a mais adequada para os nossos pacientes?
A Dra. Aanchal Gupta e o Dr. Ben LaHood apresentarão uma análise aprofundada das características óticas e do desempenho clínico da AT LISA tri em comparação com a AcrySof IQ PanOptix, e discutirão o papel do Angle Kappa na implantação das LIO multifocais.